Publications

Peer-reviewed journal articles

Updated September 2026

2026
Health Affairs Scholar
Using Prescription Drug Data for Timely Assessments of State Insurance Coverage Rates: A Validation Study
Rome BN, McIntyre A, Kim J, Han J, Kesselheim AS, Sommers BD.
View
2026
JAMA
Medicare Spending Implications for Semaglutide under Voluntary Price Agreements
Dusetzina SB, Castle G, Han J, Leech AA, Zhu J.
View
2026
Value in Health
Reanalyzing Value Assessments in American Heart Association Clinical Practice Guidelines Using Health Years in Total Instead of Quality-Adjusted Life-Years
Han J, Luviano A, Pandya A.
View
2026
Health Affairs
List Price Reductions among Brand-Name ICS-LABA Inhalers In 2024 Were Associated with Increased Generic Uptake
Han J, Wang SV, Kesselheim AS, Avorn J, Feldman WB.
View
2026
Health Affairs
Review Times for New Drugs and Submission Delays among the FDA and 4 International Regulators, 2014–22
Papanicolas I, Wouters OJ, Sawaya T, Han J, Wei J, Naci H.
View
2026
JAMA Health Forum
Changes in Medication Use during Medicaid Continuous Enrollment and Unwinding
Rome BN, Han J, McIntyre A, Kesselheim AS, Sommers BD.
View
2025
JAMA
Inhaler-related Greenhouse Gas Emissions in the US: A Serial Cross-sectional Analysis
Feldman WB, Han J, Raymakers AJN, Furie GL, Chesebro BB.
View
2025
JNCI: Journal of the National Cancer Institute
Assessing Outcomes Emerging After Conversion to Regular Approval for Cancer Drug Indications Granted Accelerated Approval Drugs, 1992-2021
Tibau A, Romano A, Liu ITT, Han J, Cliff ERS, Kesselheim AS.
View
2025
Addiction Research & Theory
Public Discourse on Substance Use Behavior as a Driver of Public Policy: A Scoping Review of South Korean Academic and Official Literature
Sung M, Han J, Wade CG, Rees VW.
View
2025
JAMA Dermatology
Use of and Cost of First-Line Biologic Medications to Treat Plaque Psoriasis in the US
Rome BN, Han J, Mooney H, Kesselheim AS.
View
2025
Health Affairs
First-in-Class Drugs Experienced Different Regulatory Treatment in the US and Europe
Han J, Kesselheim AS.
View

Peer-reviewed journal articles

Using Prescription Drug Data for Timely Assessments of State Insurance Coverage Rates: A Validation Study

Medicare Spending Implications for Semaglutide under Voluntary Price Agreements

Reanalyzing Value Assessments in American Heart Association Clinical Practice Guidelines Using Health Years in Total Instead of Quality-Adjusted Life-Years

List Price Reductions among Brand-Name ICS-LABA Inhalers In 2024 Were Associated with Increased Generic Uptake

Review Times for New Drugs and Submission Delays among the FDA and 4 International Regulators, 2014–22

Changes in Medication Use during Medicaid Continuous Enrollment and Unwinding

Inhaler-related Greenhouse Gas Emissions in the US: A Serial Cross-sectional Analysis

Assessing Outcomes Emerging After Conversion to Regular Approval for Cancer Drug Indications Granted Accelerated Approval Drugs, 1992-2021

Public Discourse on Substance Use Behavior as a Driver of Public Policy: A Scoping Review of South Korean Academic and Official Literature

Use of and Cost of First-Line Biologic Medications to Treat Plaque Psoriasis in the US

First-in-Class Drugs Experienced Different Regulatory Treatment in the US and Europe